The Impact of COVID-19 Pandemic on Thyroid Surgery in Italy: Results From a Nation-wide Multicentric Study
1 other identifier
observational
3,800
1 country
1
Brief Summary
Italy has been on the frontline of the COVID-19 pandemic, caused by the coronavirus SARS-CoV-2, the need to focus resources to deal with the pandemic led to a disruption of routine surgical care, as well as activity for oncologic and chronic disease. The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.The aim of this study was to evaluate the impact of COVID-19 pandemic on surgical activity of the Italian Units of Endocrine Surgery belonging to the SIUEC (Italian Society of Endocrine Surgery), the most important national scientific society of endocrine surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Mar 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 10, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 12, 2020
CompletedFirst Submitted
Initial submission to the registry
November 17, 2020
CompletedFirst Posted
Study publicly available on registry
November 19, 2020
CompletedNovember 19, 2020
November 1, 2020
7 months
November 17, 2020
November 18, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Quantify the overall reduction of surgical activity for thyroid disease
1 year
Secondary Outcomes (2)
Quantify if the number of thyroid cancers operated during COVID-19 pandemic was significant different from the number of patients operated during the same period of the previous year
1 year
Quantify the number of aggressive tumors operated during COVID-19 pandemic and the same period of the previous year
1 year
Study Arms (2)
Group 1 - COVID group
Patients that underwent surgery during COVID-19 pandemic
Group 2 - control group
Patients that underwent surgery during 2019
Interventions
Eligibility Criteria
Patients with thyroid disease
You may qualify if:
- patients that had undergone thyroidectomy during COVID-19 pandemic (from the 9th March to the 31st August 2020), defined as case group, or during the same period of the previous year (from the 9th Match to the 31st August 2019), defined as control group.
You may not qualify if:
- incomplete data
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
AOU Cagliari
Cagliari, CA, 09100, Italy
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 17, 2020
First Posted
November 19, 2020
Study Start
March 10, 2020
Primary Completion
September 30, 2020
Study Completion
November 12, 2020
Last Updated
November 19, 2020
Record last verified: 2020-11
Data Sharing
- IPD Sharing
- Will not share